Gastroenterology
Volume 136, Issue 7 , Pages 2101-2114.e6, June 2009

A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus

  • John M. Inadomi

      Affiliations

    • Division of Gastroenterology, San Francisco General Hospital, San Francisco, California
    • GI Health Outcomes, Policy and Economics (HOPE) Research Program, Department of Medicine, University of California, San Francisco, San Francisco, California
    • Corresponding Author InformationReprint requests John M. Inadomi, MD, San Francisco General Hospital, Room 3D-5, 1001 Potrero Avenue, San Francisco, California 94110. fax: (415) 641-0745
    • ,
  • Ma Somsouk

      Affiliations

    • Division of Gastroenterology, San Francisco General Hospital, San Francisco, California
    • GI Health Outcomes, Policy and Economics (HOPE) Research Program, Department of Medicine, University of California, San Francisco, San Francisco, California
    • ,
  • Ryan D. Madanick

      Affiliations

    • Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina
    • ,
  • Jennifer P. Thomas

      Affiliations

    • GI Health Outcomes, Policy and Economics (HOPE) Research Program, Department of Medicine, University of California, San Francisco, San Francisco, California
    • ,
  • Nicholas J. Shaheen

      Affiliations

    • Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina

Received 13 June 2008; accepted 20 February 2009. published online 09 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This article has an accompanying continuing medical education activity on page 2387. Learning Objective: Upon completion of this CME exercise, successful learners will be able to analyze current evidence regarding the risk of cancer among patients with Barrett's esophagus, interpret studies of interventions to reduce cancer incidence, and assess current guidelines with respect to emerging data of management of patients with Barrett's esophagus.

 Conflicts of interest The authors disclose the following: R. Madanick has received an honorarium and N. Shaheen and J. Inadomi have received research support from Barrx Medical, maker of the radiofrequency ablation device. The remaining authors disclose no conflicts.

 Funding Supported by grants from the National Cancer Institute (R01 CA106773 - JMI) and National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK080941 - JMI), National Institutes of Health. Supported by an unrestricted research grant from BARRX.

PII: S0016-5085(09)00348-5

doi:10.1053/j.gastro.2009.02.062

Refers to article:

  • Continuing Medical Education Exam 1, June 2009 , 04 May 2009

    Michael B. Wallace
    Gastroenterology June 2009 (Vol. 136, Issue 7, Pages 2387-2388)

Gastroenterology
Volume 136, Issue 7 , Pages 2101-2114.e6, June 2009

Article Tools

* Image Usage & Resolution